No, I don't think we'd be looking at the loss. I think we have a stable, consistent operation now. And we've done quite a bit in the last half a year to achieve that. I think what you're seeing is 2 different things, like I break it out into 2 different things. One is we have in our molded optics, in our PMO, we have really what I'd call 2 very different price ranges. And one the telecom, which is the lowest price range and single [dollars] [ph], but fairly good margin. And the other is the medical and others, which are higher unit plays and a different type of margins to them. When we added capacity, we added it because at that time, we had large telecom orders, which again are the lower unit size. And so, it is not as visible in the dollar of revenue. But you can see it very clearly in the number of units we produce, and the very nice consistent growth in that. This is not to say that it would remain forever like this. Our product mix changes and there were orders from different industry change. And we also navigate that knowing what capacity we have and what orders we want to win. It's very possible and expected that some of that capacity that we added at some point down the road, and again, telecom, usually a rollout like this 5G last for 3, 4 years. So at some point down the road, some of that capacity that we added is going to switch over to products with higher average sale prices, and we'll see the impact from the revenue. On the bottom line, I think this quarter specifically, we had a few expenses. One of them is the $300,000 tax to China for the dividend, which really impacted our earnings per share. Otherwise we would have expected our earnings per share without that expense and the couple of other onetime expenses that are important for us for the long run, but really, we don't expect them to occur every quarter. Then we expect our results, our bottom-line results continue to be as strong as we've had in the last couple of quarters.